The Research On The Investment Value Of Hubei Jumpcan Pharmaceutical Co.,Ltd.

In the early 1990 s,the Shenzhen-Shanghai Stock Exchange was successively established,which also marked the formal formation of China's stock market.With the continuous expansion of the scale of China's listed companies,China has also continuously improved relevant laws,regulations and systems to protect the legitimate rights and interests of participants in the securities market.In an open,fair and just investment environment,it continues to attract more investors to participate.However,most small and medium investors generally lack a sense of rational trading,understanding of the valuation system of listed companies and ability to accurately judge the market.Therefore,how to systematically evaluate the corporate value of listed companies,provide investors with objective risk prompts,and help investors have a relatively accurate judgment of company information is an issue that China's capital market should pay attention to.In recent years,the domestic health industry has developed rapidly under the attention of the country,and the market has huge room for growth in the future.This article mainly selects Jichuan Pharmaceutical(stock code: 600566.SH)as the target,and comprehensively analyzes the situation of Jichuan Pharmaceutical.Jichuan Pharmaceutical Co.,Ltd.went public on the backdoor(Hongcheng Stock)in 2013,and expanded its business scale through financing.Since its listing,Jichuan Pharmaceutical's net profit has grown at a compound annual growth rate of about 24%,achieving excellent results.So,does Jichuan Pharmaceutical have investment value?In order to solve the above problems,this article uses scientific research methods and theories to analyze the enterprise.It is mainly explained from the background,meaning,content,problems and research methods of this article.Aiming at the theory of analysis,the method of analysis and the description of domestic literature needed for the research.This article comprehensively analyzes the basic situation of the company,its market position and competitive advantages in the pharmaceutical industry,and explains its business goals and financial goals.It analyzes the industry's policies,developments,development prospects and competition,and analyzes the company's accounting policies and financial-related data,to understand the company'sown profitability,solvency,and growth capabilities.Absolute valuation method(free cash flow discount model)and relative valuation method(price-earnings ratio,P / B ratio,and P / S ratio)are used to value the company.The stock price of the company is determined through four different valuation methods to be 15.31 yuan,53.47 yuan,19.63 yuan and 17.07 yuan,respectively.According to this conclusion,made of macro environment,industry change,company management and product price fluctuations,such as risk analysis,through the p/e ratio estimate price is 53.47 yuan,and the other way of valuation results are huge,so this article is also done to abnormal data analysis in this paper.Combined with the analysis of current commonly used technical indicators such as MACD and RSI,comprehensive consideration,the investment in jichuan pharmaceutical can be selected to invest in the appropriate opportunities.